DHG Suomi / MediMattress Oy

DHG Suomi / MediMattress Oy is a Finnish company founded in 1998 that specializes in manufacturing medical devices for healthcare. The company's flagship product, Carital® Optiman, is designed for the prevention and treatment of pressure ulcers and is backed by strong clinical evidence. MediMattress Oy's focus on patient safety, easing the work of healthcare professionals and caregivers, and addressing the global need for cost savings in healthcare through preventative measures underpins its business operations. The company aims to develop even safer and user-friendly products and methods for current applications, with a focus on advancing anti-deformation technology. In October 2020, MediMattress Oy became a part of the British-based Direct Healthcare Group (DHG), a rapidly growing European manufacturer specializing in pressure ulcer prevention and treatment products, patient transfer, and seating solutions, in collaboration with the parent company Carital Oy. The company acts as a distributor for DHG's products, including SystemRoMedic TM transfer aids. The acquisition by DHG provides opportunities for synergies and expansion, bolstering MediMattress Oy's position in the industry. Notably, the specific details of the most recent investment and the involved investors are currently unavailable, potentially indicating a period of focusing on integration and growth within the DHG group.